He will issue an executive order allowing just 20 hospitals statewide to recommend medical marijuana for patients suffering from cancer, glaucoma, or other diseases authorized by the state Department of Health.

The move is something of a reversal for Cuomo, who has opposed medical marijuana pending in the state legislature. Cynics might suggest he is trying to burnish his progressive credentials with a limited opening, but undercut the pending bill, which would be less restrictive. In any case, the Times says he will make it official during Wednesday's state of the state speech.

Dr. Sunil Aggarwal, a prominent medical marijuana advocate, has pointed out that New York's state's Department of Health conducted medical marijuana research during the 1980s under the legislation that Cuomo cited as the legislative basis for his action. An article in the Journal of Cannabis Therapeutics discusses the New York research, which it describes as large scale and designed in accordance with FDA phase III clinical trial procedure, on pages 51-52.

Whether New York can move forward with this kind of program in the absence of licensing that the DEA in recent decades has refused to grant is unclear. Along with recent legislation passed in Maryland calling for medical marijuana distribution academic medical centers, and petitions filed by the governors of Rhode Island and Washington state, it should at least up the pressure on the administration to rein in DEA's obstruction on this issue.